9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
H. Lee Moffitt Cancer Center and Research Institute
Immodulon Therapeutics Ltd
Emory University
Henan Cancer Hospital
OHSU Knight Cancer Institute
Swiss Cancer Institute
Grupo Espanol de Investigacion en Sarcomas
Celgene
Western Regional Medical Center
Stanford University